Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer
Summary
Responses observed in patients with and without previous exposure to other KRAS G12C inhibitors
Description
Responses observed in patients with and without previous exposure to other KRAS G12C inhibitors
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source